https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-92013-03-21 00:00:002019-02-15 08:36:01Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-18 / J. Interferon Cytokine Res. 2013 Jul;33(7):346-542013-03-18 00:00:002013-03-18 00:00:00The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-13 / PLoS One 2013;8(3):e59051
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-13 / PLoS One 2013;8(3):e590512013-03-13 00:00:002013-03-13 00:00:00A low selenium level is associated with lung and laryngeal cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-04 / Hum Vaccin Immunother 2013 Jun;9(6):1217-272013-03-04 00:00:002019-02-15 08:48:05Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-03-01 / Oncoimmunology 2013 Mar;2(3):e23401
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-03-01 / Oncoimmunology 2013 Mar;2(3):e234012013-03-01 00:00:002019-02-15 08:47:41The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
